Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Affymax Questions & Answers

How do I buy Affymax (AFFY) stock?

You can purchase shares of Affymax (OTCEM: AFFY) through any online brokerage.

View our list of the best stock brokerages.

Who are Affymax's (AFFY) competitors?

There are no as such competitors for Affymax.

What is the target price for Affymax (AFFY) stock?

The latest price target for Affymax (OTCEM: AFFY) was reported by McNicoll Lewis Vlak on Tuesday, March 19, 2013. The analyst firm set a price target for 0.50 expecting AFFY to rise to within 12 months (a possible 7964.52% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Affymax (AFFY)?

The stock price for Affymax (OTCEM: AFFY) is $0.0062 last updated July 5, 2022, 1:55 PM UTC.

Does Affymax (AFFY) pay a dividend?

There are no upcoming dividends for Affymax.

When is Affymax (OTCEM:AFFY) reporting earnings?

Affymax does not have any upcoming earnings scheduled.

Is Affymax (AFFY) going to split?

There is no upcoming split for Affymax.

What sector and industry does Affymax (AFFY) operate in?

Affymax is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Affymax (OTC:AFFY), Quotes and News Summary

Analyst Ratings

Affymax Questions & Answers